Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties
about
IRF7: activation, regulation, modification and functionInterferon regulatory factor 4 is involved in Epstein-Barr virus-mediated transformation of human B lymphocytesThe viral etiology of AIDS-associated malignanciesDual functions of interferon regulatory factors 7C in Epstein-Barr virus-mediated transformation of human B lymphocytesInterferon regulatory factor 7 is negatively regulated by the Epstein-Barr virus immediate-early gene, BZLF-1Interferon regulatory factor 5 represses expression of the Epstein-Barr virus oncoprotein LMP1: braking of the IRF7/LMP1 regulatory circuit.NF-κB and IRF7 pathway activation by Epstein-Barr virus Latent Membrane Protein 1Toll-like receptor 7 stimulates the expression of Epstein-Barr virus latent membrane protein 1Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF)The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.Interferon regulatory factor 4 (IRF-4) targets IRF-5 to regulate Epstein-Barr virus transformation.Interferon regulatory factor 7 is activated by a viral oncoprotein through RIP-dependent ubiquitination.Knockout of Epstein-Barr virus BPLF1 retards B-cell transformation and lymphoma formation in humanized mice.Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.TLR-TRIF pathway enhances the expression of KSHV replication and transcription activator.The Kaposi's Sarcoma-associated Herpesvirus-encoded vIRF-3 Inhibits Cellular IRF-5Truncation of histone H2A's C-terminal tail, as is typical for Ni(II)-assisted specific peptide bond hydrolysis, has gene expression altering effectsInterferon regulatory factor 7 functions as a novel negative regulator of pathological cardiac hypertrophyTumor Suppressor p53 Stimulates the Expression of Epstein-Barr Virus Latent Membrane Protein 1.The Linear Ubiquitin Assembly Complex Modulates Latent Membrane Protein 1 Activation of NF-κB and Interferon Regulatory Factor 7.LMP1 signaling pathway activates IRF4 in latent EBV infection and a positive circuit between PI3K and Src is required.Interferon regulatory factor 4 is activated through c-Src-mediated tyrosine phosphorylation in virus-transformed cells.Interferon regulatory factor 7 regulates glioma stem cells via interleukin-6 and Notch signalling.IRF7 regulates the development of granulocytic myeloid-derived suppressor cells through S100A9 transrepression in cancer.The Translesion Polymerase Pol η Is Required for Efficient Epstein-Barr Virus Infectivity and Is Regulated by the Viral Deubiquitinating Enzyme BPLF1.Expression of interferon regulatory factor 7 correlates with the expression of Epstein-Barr Virus latent membrane protein 1 and cervical lymph node metastasis in nasopharyngeal cancer.Epstein-Barr virus inhibits Kaposi's sarcoma-associated herpesvirus lytic replication in primary effusion lymphomas.The latent membrane protein 1 of Epstein-Barr virus (EBV) primes EBV latency cells for type I interferon production.Nuclear factor κB represses the expression of latent membrane protein 1 in Epstein-Barr virus transformed cells.The IRF family of transcription factors: Inception, impact and implications in oncogenesis.LIMD1 is induced by and required for LMP1 signaling, and protects EBV-transformed cells from DNA damage-induced cell death.Differential expression patterns of IRF3 and IRF7 in pediatric lymphoid disorders.
P2860
Q24299740-4968EFCF-8634-4F04-8374-BF4B788780D1Q24646670-77A8C5AB-6C94-4549-9AEE-95D4DB30283AQ24685892-33933AE1-3284-4DE1-B4C4-CEEA98EA5A8CQ30979226-66088185-B9F9-4A0B-9752-9E896BCDA977Q33908810-A6E20B3D-E866-4329-B794-5A1B241FCAA0Q33987481-C06CFE9C-E0D4-4AB4-BBA1-06290BD012ECQ34352790-10068BC2-69E7-4DB4-9176-48240961677EQ34405076-C6BC6402-95BB-40E6-BAC5-67C7A7AE59C3Q34624150-CC18D327-9E25-4A7F-AB54-A95E0C59F033Q34711793-399840C5-2C6A-48A8-A65B-6020988ADB91Q34979127-33AC1B79-73C8-4D03-BA1C-3964F1FD9175Q35856781-BC41ACD2-34D5-46C7-99D2-F2E808C109ECQ36205880-A9014A1B-75A8-4399-8282-F12B0F4E5AB7Q36433837-0D7CD53D-DBBC-4F04-A7E3-A59D950E5088Q37012458-64D49BA3-F687-4504-9FDA-FC4B74CC753BQ37136785-EBDB0C55-1F2F-4EE0-BE9A-DAF1C8270565Q37409379-8D6EF35B-77E6-47D5-AAFC-91EEF0C8E923Q37698309-48C707D1-E360-41DE-BC04-3625060100CCQ38631755-B25DC299-0D88-40FD-9BE6-D6926D440189Q38728203-F88489DE-D20A-4C51-9A87-BF8773E3E0AAQ38732564-DF92CBFD-E9FA-4F12-A6E8-1B76C159E27EQ39134387-3FC46ED6-D6F3-4A03-83C3-CCD42FB138E7Q39376212-6402E6C1-FC9F-4C60-A6E3-F13390D5ACD8Q39613201-694F3CB6-45CC-413A-A47F-81C76DAAFBE6Q40116028-4CA6A269-B87E-404A-82D2-27AE5C991431Q40121289-34AA55D7-46DF-4BBA-AFEF-E0468ED23863Q40155828-8F058707-E7BA-445A-9C48-5595449B41EEQ40318357-F235F6F8-60CD-49E0-8DE0-444511B752FEQ41662260-FC3B4D34-104C-4CB2-9ED7-A2532DB1ED11Q41888239-88E3FC86-FBCE-4EC8-BF3B-13B2A8F70A61Q49787520-70A47077-0AAD-4D0E-8756-0D24A7498194Q53574392-EEF5E141-E8A2-4909-8C3C-B3A4AF010AE4
P2860
Interferon regulatory factor 7 is associated with Epstein-Barr virus-transformed central nervous system lymphoma and has oncogenic properties
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on December 2004
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Interferon regulatory factor 7 ...... a and has oncogenic properties
@en
Interferon regulatory factor 7 ...... and has oncogenic properties.
@nl
type
label
Interferon regulatory factor 7 ...... a and has oncogenic properties
@en
Interferon regulatory factor 7 ...... and has oncogenic properties.
@nl
prefLabel
Interferon regulatory factor 7 ...... a and has oncogenic properties
@en
Interferon regulatory factor 7 ...... and has oncogenic properties.
@nl
P2093
P2860
P1433
P1476
Interferon regulatory factor 7 ...... a and has oncogenic properties
@en
P2093
Channing J Der
Joseph S Pagano
Kamel Khalili
Luis Del Valle
Luwen Zhang
Que Lambert
P2860
P304
12987-12995
P356
10.1128/JVI.78.23.12987-12995.2004
P407
P577
2004-12-01T00:00:00Z